PriceTargets.com logo

RXO - RXO Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $26.47
  • Forecasted Upside: 5.87%
  • Number of Analysts: 17
  • Breakdown:
  • 2 Sell Ratings
  • 12 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$25.00 As of 12/20/2024 06:31 PM ET
▲ +0.17 (0.68%)

This chart shows the closing price for RXO by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New RXO Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for RXO and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for RXO

Analyst Price Target is $26.47
▲ +5.87% Upside Potential
This price target is based on 17 analysts offering 12 month price targets for RXO in the last 3 months. The average price target is $26.47, with a high forecast of $33.00 and a low forecast of $12.00. The average price target represents a 5.87% upside from the last price of $25.00.

This chart shows the closing price for RXO for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 17 polled investment analysts is to hold stock in RXO. This rating has held steady since June 2024, when it changed from a Reduce consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 5 buy ratings
  • 13 hold ratings
  • 0 sell ratings
Ratings as of
6/29/2023
  • 0 strong buy ratings
  • 5 buy ratings
  • 12 hold ratings
  • 1 sell ratings
Ratings as of
9/27/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 8 hold ratings
  • 3 sell ratings
Ratings as of
12/26/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 7 hold ratings
  • 3 sell ratings
Ratings as of
3/25/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 8 hold ratings
  • 3 sell ratings
Ratings as of
6/23/2024
  • 0 strong buy ratings
  • 3 buy ratings
  • 9 hold ratings
  • 2 sell ratings
Ratings as of
9/21/2024
  • 0 strong buy ratings
  • 3 buy ratings
  • 12 hold ratings
  • 2 sell ratings
Ratings as of
11/20/2024
  • 0 strong buy ratings
  • 3 buy ratings
  • 12 hold ratings
  • 2 sell ratings
Ratings as of
12/20/2024

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 12 hold ratings
  • 2 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
11/18/2024The Goldman Sachs GroupReiterated RatingNeutral$29.00
11/12/2024SusquehannaLower TargetNegative ➝ Negative$16.00 ➝ $12.00
11/12/2024CitigroupDowngradeBuy ➝ Neutral$33.00 ➝ $33.00
11/11/2024Wells Fargo & CompanyReiterated RatingEqual Weight ➝ Equal Weight$31.00
10/15/2024BenchmarkReiterated RatingHold
10/9/2024CitigroupInitiated CoverageBuy$33.00
9/26/2024SusquehannaLower TargetNegative ➝ Negative$20.00 ➝ $16.00
9/17/2024OppenheimerReiterated RatingOutperform ➝ Outperform$31.00 ➝ $31.00
8/15/2024SusquehannaBoost TargetNegative ➝ Negative$14.00 ➝ $20.00
8/13/2024Jefferies Financial GroupLower TargetBuy ➝ Buy$33.00 ➝ $31.00
8/13/2024BenchmarkReiterated RatingHold
8/12/2024Morgan StanleyBoost TargetEqual Weight ➝ Equal Weight$19.00 ➝ $26.00
8/8/2024TD CowenBoost TargetHold ➝ Hold$23.00 ➝ $28.00
8/8/2024JPMorgan Chase & Co.Boost TargetUnderweight ➝ Underweight$25.00 ➝ $26.00
8/8/2024OppenheimerBoost TargetOutperform ➝ Outperform$22.00 ➝ $31.00
8/8/2024UBS GroupBoost TargetNeutral ➝ Neutral$22.00 ➝ $31.00
7/16/2024BarclaysBoost TargetOverweight ➝ Overweight$24.00 ➝ $30.00
7/9/2024JPMorgan Chase & Co.Boost TargetUnderweight ➝ Underweight$16.00 ➝ $25.00
6/12/2024BenchmarkReiterated RatingHold
5/15/2024Raymond JamesInitiated CoverageMarket Perform
5/6/2024StephensReiterated RatingEqual Weight ➝ Equal Weight$22.00
5/3/2024TD CowenBoost TargetHold$19.00 ➝ $20.00
4/19/2024BenchmarkReiterated RatingHold
3/25/2024SusquehannaBoost TargetNegative ➝ Negative$15.00 ➝ $16.00
2/13/2024OppenheimerLower TargetOutperform ➝ Outperform$23.00 ➝ $22.00
2/9/2024SusquehannaLower TargetNegative ➝ Negative$18.00 ➝ $15.00
2/9/2024TD CowenBoost TargetMarket Perform$16.50 ➝ $19.50
2/8/2024Bank of AmericaDowngradeBuy ➝ Neutral$25.00 ➝ $22.00
1/10/2024Stifel NicolausBoost TargetHold ➝ Hold$20.00 ➝ $22.00
1/10/2024Vertical ResearchDowngradeBuy ➝ Hold$23.00
10/16/2023Stifel NicolausLower TargetHold ➝ Hold$19.00 ➝ $17.00
10/11/2023JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight$17.00 ➝ $16.00
10/3/2023SusquehannaLower TargetNegative ➝ Negative$14.00 ➝ $13.00
10/2/2023Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$20.00 ➝ $18.00
8/7/2023OppenheimerReiterated RatingOutperform ➝ Outperform$24.00
8/3/2023Morgan StanleyReiterated RatingEqual Weight ➝ Equal Weight$20.00
8/3/2023StephensLower TargetEqual Weight ➝ Equal Weight$23.00 ➝ $19.00
7/12/2023Wolfe ResearchDowngradePeer Perform ➝ Underperform$18.00
6/29/2023SusquehannaLower Target$20.00 ➝ $19.00
6/9/2023SusquehannaInitiated CoverageNeutral$20.00
5/24/2023BarclaysInitiated CoverageOverweight$27.00
4/4/2023BenchmarkInitiated CoverageHold
2/27/2023CowenInitiated CoverageMarket Perform$22.00
2/27/2023CowenInitiated CoverageMarket Perform$22.00
2/9/2023The Goldman Sachs GroupBoost TargetNeutral$20.00 ➝ $22.00
2/9/2023UBS GroupBoost TargetNeutral$20.00 ➝ $23.00
2/9/2023OppenheimerBoost TargetOutperform$21.00 ➝ $24.00
2/8/2023StephensReiterated RatingEqual Weight$20.00
1/11/2023Stifel NicolausDowngradeBuy ➝ Hold$20.00 ➝ $17.00
1/9/2023JPMorgan Chase & Co.Initiated CoverageNeutral$19.00
12/20/2022Wells Fargo & CompanyInitiated CoverageEqual Weight$18.00
12/9/2022UBS GroupInitiated CoverageNeutral$20.00
12/9/2022Morgan StanleyInitiated CoverageEqual Weight$20.00
12/6/2022Jefferies Financial GroupInitiated CoverageBuy$25.00
12/5/2022Raymond JamesInitiated CoverageMarket Perform
11/30/2022Bank of AmericaInitiated CoverageBuy$22.00
11/22/2022OppenheimerInitiated CoverageOutperform$21.00
11/22/2022The Goldman Sachs GroupInitiated CoverageNeutral$20.00
11/21/2022Vertical ResearchInitiated CoverageBuy$27.00
11/10/2022Wolfe ResearchInitiated CoveragePeer Perform
11/4/2022Stifel NicolausInitiated CoverageBuy$20.00
11/2/2022StephensInitiated CoverageEqual Weight
(Data available from 12/21/2019 forward)

News Sentiment Rating

0.90 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 15 very positive mentions
  • 12 positive mentions
  • 5 negative mentions
  • 2 very negative mentions
Mentions as of
5/25/2024
  • 12 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/24/2024
  • 9 very positive mentions
  • 10 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/24/2024
  • 17 very positive mentions
  • 29 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
Mentions as of
8/23/2024
  • 10 very positive mentions
  • 16 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
9/22/2024
  • 11 very positive mentions
  • 17 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
10/22/2024
  • 14 very positive mentions
  • 22 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
11/21/2024
  • 27 very positive mentions
  • 10 positive mentions
  • 3 negative mentions
  • 3 very negative mentions
Mentions as of
12/21/2024

Current Sentiment

  • 27 very positive mentions
  • 10 positive mentions
  • 3 negative mentions
  • 3 very negative mentions

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

RXO logo
RXO, Inc. provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.
Read More

Today's Range

Now: $25.00
Low: $23.81
High: $25.15

50 Day Range

MA: $28.46
Low: $24.83
High: $31.90

52 Week Range

Now: $25.00
Low: $18.75
High: $32.82

Volume

6,142,710 shs

Average Volume

886,796 shs

Market Capitalization

$4.02 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.32

Frequently Asked Questions

What sell-side analysts currently cover shares of RXO?

The following Wall Street analysts have issued stock ratings on RXO in the last year: Bank of America Co., Barclays PLC, Benchmark Co., Citigroup Inc., Jefferies Financial Group Inc., JPMorgan Chase & Co., Morgan Stanley, Oppenheimer Holdings Inc., Raymond James, Stephens, Stifel Nicolaus, Susquehanna, TD Cowen, The Goldman Sachs Group, Inc., UBS Group AG, Vertical Research, and Wells Fargo & Company.
View the latest analyst ratings for RXO.

What is the current price target for RXO?

0 Wall Street analysts have set twelve-month price targets for RXO in the last year. Their average twelve-month price target is $26.47, suggesting a possible upside of 5.9%. Citigroup Inc. has the highest price target set, predicting RXO will reach $33.00 in the next twelve months. Susquehanna has the lowest price target set, forecasting a price of $12.00 for RXO in the next year.
View the latest price targets for RXO.

What is the current consensus analyst rating for RXO?

RXO currently has 2 sell ratings, 12 hold ratings and 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in RXO, but not buy more shares or sell existing shares.
View the latest ratings for RXO.

What other companies compete with RXO?

Other companies that are similar to RXO include Brookfield Infrastructure Partners, TFI International, MakeMyTrip, Plains All American Pipeline and ZTO Express (Cayman). Learn More about companies similar to RXO.

How do I contact RXO's investor relations team?

The company's listed phone number is 980-308-6058 and its investor relations email address is [email protected]. The official website for RXO is www.rxo.com. Learn More about contacing RXO investor relations.